Variants of Kaposi's Sarcoma in Southern Africa a Retrospective Analysis (1980-1992)

Authors

  • Moshe E. Stein Northern Israel Oncology Center and Insitute of Gastroenterology Rambam Medical Center Haifa, Israel; University of the Withatersrand, Johannesburg General Hospital Johannesburg, South Africa
  • Jesse Lachter Department of Medical Oncology and Clinical Haifa Johannesburg, South Africa
  • David Spencer Department of Medical Oncology and Clinical Haifa Johannesburg, South Africa
  • Larry Margolius Department of Medical Oncology and Clinical hematology, South Africa
  • Werner R. Bezwoda University of the Withatersrand, Johannesburg General Hospital Johannesburg, South Africa

DOI:

https://doi.org/10.3109/02841869609098501

Abstract

All types of Kaposi's sarcoma (KS) are represented in the Southern African region. We present a retrospective analysis of patients with KS, treated and followed up at the Johannesburg General Hospital over a 12-year period (1980-1992). One hundred and nineteen patients with KS, divided into four groups according to their etiology (classical; endemic African; renal transplant recipients; epidemic AIDS-related) were analyzed. Choice of treatment (radiotherapy or chemotherapy) was individualized and based on clinical criteria, extent of disease and severity of symptoms. Kaposi's sarcoma showed a very high response rate to radiation therapy, regardless of variant, radiation modality or schedule. Chemotherapy was also effective in the more aggressive pattern of endemic African KS. Epidemic Kaposi's sarcoma showed the same poor outcome as demonstrated by its Western counterpart. We conclude that radiation therapy can provide excellent palliation with only minimal side-effects in all variants of KS seen in Southern Africa.

Downloads

Download data is not yet available.

Downloads

Published

1996-01-01

How to Cite

Stein, M. E., Lachter, J., Spencer, D., Margolius, L., & Bezwoda, W. R. (1996). Variants of Kaposi’s Sarcoma in Southern Africa a Retrospective Analysis (1980-1992). Acta Oncologica, 35(2), 193–199. https://doi.org/10.3109/02841869609098501